Cipla USA, Inc. recalls Lanreotide Injection, 120 mg/0.5 mL, Box contains 1 Pre-filled syringe, Single dose only, Rx Only, Manufactured by: Pharmathen…

Lack of Assurance of Sterility: Due to an FDA observation at the contract manufacturing site for deficiencies in their visual inspection procedure.

Date

2026-04-15

Country

United States

Brand

Cipla

Product

Lanreotide Injection, 120 mg/0.5 mL, Box contains 1 Pre-filled syringe, Single dose only, Rx Only, Manufactured by: Pharmathen…

Classification

Class II

Units

Nationwide in the USA

Category

Drugs & medical

Source

FDA · Drug

Copied automatically from the US Food and Drug Administration. Details may be shortened or out of date; the official notice is the authoritative source. Disclaimer

What to do

1. Check the product name, strength and lot number against the official notice.
2. Do not stop a prescribed medicine without talking to your doctor or pharmacist first.
3. Ask the pharmacy or supplier about a replacement or refund.

General guidance from Recall Atlas. The official notice from the US Food and Drug Administration has the exact models, batch codes and remedy, and it takes priority.

More Cipla recalls

1. 2026-10-14
2. US
   Drugs & medicalClass II

   Cipla USA, Inc. recalls Fosfomycin Tromethamine Granules for Oral Solution, (Equivalent to 3 Grams of Fosfomycin), 1 Single-Dose Sachet, Rx only, Manufactured by:…

   Failed Impurities/Degradation Specifications

   FDA · DrugCipla USA, Inc.USA Nationwide.Official notice →
3. 2026-07-08
4. US
   Drugs & medicalClass II

   Cipla USA, Inc. recalls Cinacalcet Hydrochloride Tablets, 30 mg, 30-count bottle, Rx Only, Manufactured by: Cipla Ltd., MIDC, Patalganga, India; Manufactured for:…

   cGMP Deviations: presence of N-nitroso-cinacalcet, above the acceptable daily intake (ADI).

   FDA · DrugCipla USA, Inc.USA NationwideOfficial notice →
5. 2026-04-22
6. US
   Drugs & medicalClass II

   Cipla USA, Inc. recalls Cinacalcet Hydrochloride Tablets, 30 mg, 30 Tablets per bottle, Rx Only, Manufactured by: Cipla Ltd., MIDC, Patalganga, India;…

   CGMP Deviations; presence N-Nitroso Cinacalcet above the acceptable daily intake limit

   FDA · DrugCipla USA, Inc.Nationwide in the USAOfficial notice →
7. 2026-03-11
8. US
   Drugs & medicalClass III

   Cipla USA, Inc. recalls Nilotinib Capsules, 150 mg per capsule, packaged in cartons, Rx only, Manufactured by: Cipla Ltd., Verna, Goa, India, Manufactured for:…

   Failed Tablet/Capsule Specifications: Observed OOS results at 6-months long-term stability condition for Description test and Appearance by Visual Inspection test.

   FDA · DrugCipla USA, Inc.U.S.A. NationwideOfficial notice →
9. 2026-01-28
10. US
    Drugs & medicalClass III

    Cipla USA, Inc. recalls Diclofenac Sodium Topical Gel, 1%, NET WT 100 g (3.53 oz), Manufactured by: DPT Laboratories, Ltd., 307 E Josephine Street, San Antonio,…

    Failed PH Specifications

    FDA · DrugCipla USA, Inc.Nationwide in the USAOfficial notice →
11. 2026-01-21
12. US
    Drugs & medicalClass II

    Cipla USA, Inc. recalls Lanreotide Injection, 120 mg/0.5 mL, 0.5 mL per pre-filled syringe, For deep subcutaneous injection, Rx Only, Manufactured for: Cipla USA,…

    Presence of Particulate Matter.

    FDA · DrugCipla USA, Inc.Nationwide in the USAOfficial notice →

Other drugs & medical recalls in the United States

1. 2026-04-15
2. US
   Drugs & medicalClass II

   Preferred Pharmaceuticals, Inc. recalls Artificial Tears Lubricant Eye Drops (glycerin 0.2%, hypromellose 0.2%, polyethylene glycol 400 1%), 0.5 oz bottles, Mfg:…

   Lack of Assurance of Sterility

   FDA · DrugPreferred Pharmaceuticals, Inc.Nationwide within the United StatesOfficial notice →
3. US
   Drugs & medicalClass II

   Fagron Compounding Services recalls Vancomycin HCI, 1.5 grams added to 250 mL, 0.9% Sodium Chloride Injection USP, Fagron Sterile Services, 8710 34th St. N. Wichita, KS…

   Lack of Assurance of Sterility; blue Break-Off-Part could detach from the administration port

   FDA · DrugFagron Compounding ServicesNationwide in the U.S.A.Official notice →
4. US
   Drugs & medicalClass II

   Fresenius Kabi USA, LLC recalls 0.9% Sodium Chloride Injection, USP, (2,250 mg per 250 mL) (9 mg per mL) 250 mL in a 250 mL freeflex bag, Rx only, Fresenius Kabi USA,…

   Lack of Assurance of Sterility

   FDA · DrugFresenius Kabi USA, LLCUS Nationwide , Alaska, and Puerto Rico.Official notice →
5. 2026-04-08
6. US
   Drugs & medicalClass II

   Cardinal Health 200, LLC recalls Cardinal Health Monoject Tuberculin Syringe, 1 mL Luer Lock, Catalog Number 1180100777

   The outer packaging and blister pack labeling identify the product as 1mL Luer Lock Tuberculin Syringe (Product Code 1180100777), however the syringes contained within the packages are U-100 Insulin syringes.

   FDA · DeviceCardinal Health 200, LLCWorldwide distribution - US Nationwide and the country of Canada.Official notice →
7. US
   Drugs & medicalClass II

   GE Healthcare LLC recalls SIGNA Premier systems

   Whole-Body MR scanners used to produce images of the inside of the human body to aid diagnosis of disease may have been manufactured/serviced with ferrous (steel) fittings instead of non-ferrous (brass) fittings on the…

   FDA · DeviceGE Healthcare LLCWorldwide - US Nationwide distribution in the states of CA, MA, NJ, NY, OH,…Official notice →
8. US
   Drugs & medicalClass II

   Oxoid Australia Pty Limited recalls OXOID MICROBACT IDENTIFICATION KITS, Listeria 12L Kit, 20 Tests; Listeria identification sysystem

   Oxoid Ltd., part of Thermo Fisher Scientific, confirmed that Microbact 12L Kit 20 Tests MB1128A lot 4494873 may identify incorrect organism due to inconclusive result from ambiguous color reactions in wells.

   FDA · DeviceOxoid Australia Pty LimitedUS Nationwide distribution in the states of GA and CA.Official notice →